Is CDX.AX stock a buy after the recent drop?

CDX.AX stock looks oversold but fundamentals are weak. Traders may buy small positions for a technical bounce. Long-term investors should wait for cash flow improvement or clear commercial wins. This is not financial advice.

What is Meyka AI's forecast for CDX.AX stock?

Meyka AI's forecast model projects A$0.02288 for CDX.AX stock over 12 months, implying a model-based downside of about -36.46% from A$0.036. Forecasts are model-based projections and not guarantees.

What short-term price target should traders use for CDX.AX stock?

For an oversold bounce, a short-term technical target is A$0.060, with a tighter stop at A$0.028. Use small position sizes due to thin liquidity and headline-driven moves.

How does CardieX's balance sheet affect CDX.AX stock risk?

CardieX has a current ratio of 1.56 and debt-to-equity of 0.66, but operating cash flow per share is negative at -A$0.026. That increases funding risk and means stock moves can be volatile on financing news.

AU Stocks

A$0.036 CDX.AX CardieX ASX Market Closed 21 Jan 2026: Oversold bounce

ByHuzaifa Zahoor January 21, 2026January 21, 2026

CardieX Limited (CDX.AX) closed at A$0.036 on the ASX on 21 Jan 2026, creating an oversold bounce setup for short-term traders. CDX.AX stock trades below its 50-day average of A$0.032 and far below its 200-day average of A$0.065. Volume was 176,535 shares, below the 30-day average volume of 458,209. The company’s YTD move of -63.64% signals heavy selling, but low float and recent volume spikes can fuel a technical rebound. We examine catalysts, valuation, and a tight trading plan for an oversold bounce.